Harvard and Research Community Warn of Threat to Innovation as OMB Proposes Overhaul of Federal Grant Framework

The federal landscape for research and development is facing its most significant transformation in over a decade as the Office of Management and Budget (OMB) moves to finalize a sweeping overhaul of the Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. Known formally as the Uniform Guidance, this framework serves as the foundational "rules of the road" for how more than $1 trillion in federal grants are allocated, managed, and audited annually. On May 29, the OMB, in coordination with several federal grantmaking agencies, released a series of proposed revisions that have sent shockwaves through the American academic and scientific communities. The proposed changes would fundamentally alter the selection process for federally funded research, granting political appointees unprecedented authority over funding decisions and expanding the government’s power to terminate active grants based on shifting policy priorities rather than scientific performance.

The public response to the proposal has been overwhelming, reflecting the high stakes for the nation’s innovation ecosystem. Before the public comment window closed on July 13, nearly 500,000 comments were submitted to the federal register, with a vast majority of respondents—ranging from individual researchers to major multi-state research consortiums—expressing deep opposition. Harvard University, a primary stakeholder in the federal research partnership, submitted three distinct comment letters from the central University administration, Harvard Medical School, and the T.H. Chan School of Public Health. These letters collectively urge the OMB to reconsider the revisions, warning that the new rules could dismantle the merit-based peer-review system that has defined American scientific leadership since the end of World War II.

A Chronology of the Regulatory Overhaul

The path toward this proposed overhaul began in early 2024, following a series of executive orders aimed at aligning federal spending more closely with the administration’s broader policy objectives. The formal proposal was unveiled on May 29, 2026, marking the first major attempt to restructure the Uniform Guidance since its inception in 2014. The 2014 framework was originally designed to streamline the administrative burden on grant recipients while ensuring taxpayer dollars were used efficiently. However, the 2026 proposal shifts the focus from administrative efficiency to discretionary oversight.

Following the May announcement, a 45-day public comment period ensued, concluding on July 13. During this window, the research community mobilized at an unprecedented scale. Organizations such as the Association of American Universities (AAU) and the Council on Governmental Relations (COGR) issued briefings to their members, highlighting the potential for "political interference" in the scientific process. With the comment period now closed, the OMB is legally mandated to review the feedback and provide justifications for any rules that remain in the final version. A final rule is anticipated to be issued as early as October 1, 2026, which would trigger a rapid implementation phase across all federal agencies, including the National Institutes of Health (NIH), the National Science Foundation (NSF), and the Department of Defense (DOD).

The Shift from Merit to Mandate

The most contentious element of the OMB proposal is the introduction of new layers of political oversight in the grant-awarding process. For decades, the "gold standard" of U.S. research has been the merit-based peer-review system. Under this model, scientists and experts in specific fields evaluate research proposals based on their technical feasibility, scientific significance, and potential for breakthrough. While federal agencies set the broad priorities—such as focusing on cancer research or renewable energy—the specific projects chosen for funding are determined by those with the expertise to judge the work’s quality.

The new OMB rules would allow political appointees within federal agencies to override these expert recommendations. John H. Shaw, Harvard’s senior vice provost for research, notes that this change threatens the very underpinnings of the innovation ecosystem. By making funding decisions susceptible to political winds, the government risks creating a "stop-and-go" environment for science. Research, particularly in fields like physics or biology, often requires decades of sustained effort. If the criteria for funding shift every four years based on the prevailing political leadership, long-term projects may lose the stability required to achieve significant breakthroughs.

Furthermore, the proposal grants agencies expanded authority to suspend or terminate grants midstream for reasons other than "cause" (such as misconduct or failure to meet milestones). This "at-will" termination power could be used to halt research that is no longer aligned with a changing administration’s platform. Critics argue that this creates a climate of risk aversion among faculty, who may be hesitant to hire doctoral students or invest in specialized equipment if their funding could be pulled at any moment.

The Indirect Cost Debate and Institutional Infrastructure

Another pillar of the OMB proposal concerns the recovery of "indirect costs," often referred to as Facilities and Administrative (F&A) costs. These are the funds that support the essential infrastructure of research—building maintenance, high-speed data networks, hazardous waste disposal, and compliance with federal safety and security regulations. Unlike direct costs, which pay for researcher salaries and laboratory supplies, indirect costs cover the "hidden" expenses that make research possible.

The proposed rules suggest that an institution’s indirect cost recovery rate could be used as a "thumb on the scale" during the competitive bidding process. Agencies would be encouraged to favor institutions with lower indirect cost rates. While this may seem like a cost-saving measure for the taxpayer, experts warn it is a false economy. Institutions with higher rates are often those that have invested most heavily in state-of-the-art laboratory facilities and robust compliance offices.

If federal funding is diverted away from these high-capacity institutions in favor of those with lower overhead, it could disincentivize universities from investing in the very infrastructure needed for cutting-edge science. Furthermore, because administrative costs are already capped by federal law, the differences in rates between universities primarily reflect the age, location, and complexity of their physical laboratories. Favoring low-cost facilities could inadvertently steer research away from the nation’s most advanced hubs of innovation.

National Security and Global Competitiveness

The implications of these changes extend far beyond the campus gates of institutions like Harvard. The U.S. research enterprise is a critical component of national security and economic vitality. From the development of GPS to the creation of the internet and the rapid deployment of mRNA vaccines, federal grants have been the catalyst for technologies that define modern life.

The Harvard comment letters emphasize that the proposed rules could harm the nation’s ability to attract and retain global talent. International students and researchers are drawn to the U.S. because of the stability and integrity of its scientific process. If the system becomes viewed as unpredictable or politically motivated, the best minds may choose to pursue their work in Europe or Asia, where research frameworks are often more insulated from political shifts.

The case of quantum science serves as a poignant example. Decades ago, quantum physics was a niche academic interest. Sustained federal investment through the NSF and DOD allowed researchers to explore fundamental questions that are only now resulting in quantum computers and secure communication networks. Had these projects been subjected to the proposed termination rules during their "unforeseen potential" phase, the U.S. might not currently hold its competitive edge in this vital field.

Case Studies: The Cost of Interruption

To illustrate the danger of midstream grant terminations, Harvard researchers pointed to the "wave of mass federal grant terminations" experienced in 2025. During that period, several high-stakes projects faced sudden halts, resulting in the loss of years of data and the dispersal of highly trained research teams.

One such project involved "organ-on-a-chip" technology developed at the Wyss Institute for Biologically Inspired Engineering. This technology allows scientists to test human cell responses to drugs and radiation without animal testing. A specific application of this research involved human cells from Artemis mission astronauts, designed to study the effects of deep-space radiation. Because the project was tied to a specific launch window, any interruption in funding would have rendered the entire experiment moot. Under the proposed OMB rules, such vital projects would be perpetually at risk of being sidelined by bureaucratic or political shifts, regardless of their scientific importance.

Similarly, the development of CRISPR gene-editing technology, which has revolutionized the treatment of blood diseases like sickle cell anemia, relied on decades of incremental, federally funded research. These breakthroughs do not happen in "eureka" moments that fit neatly into four-year political cycles; they are the result of a stable, meritocratic partnership between the government and academia.

Looking Ahead: The October Deadline

As the October 1 deadline for the final rule approaches, the academic community remains in a state of high alert. The OMB is currently processing the half-million comments, a task of significant administrative magnitude. Legal experts suggest that if the OMB fails to adequately address the criticisms raised by stakeholders like Harvard, the final rules could face immediate challenges in federal court under the Administrative Procedure Act, which requires agencies to engage in "reasoned decision-making."

For now, researchers across the country are left to navigate a period of profound uncertainty. The outcome of this regulatory battle will determine whether the next generation of American scientists operates in a system governed by the pursuit of knowledge or one increasingly shaped by the shifting priorities of Washington. As Senior Vice Provost John Shaw concluded in his interview with the Gazette, the goal of the feedback process is to ensure the government "gets this right," noting that the health, security, and prosperity of the American public depend on the continued integrity of the federal research partnership.